Company

Lattice Biologics Ltd

Headquarters: Belgrade, MT, United States

CEO: Mr. Guy S. Cook

OTC: LBLTF

Market Cap

$40,665

USD as of Jan. 1, 2024

Market Cap History

Lattice Biologics Ltd market capitalization over time

Evolution of Lattice Biologics Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Lattice Biologics Ltd

Detailed Description

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Lattice Biologics Ltd has the following listings and related stock indices.


Stock: OTC: LBLTF wb_incandescent

Stock: TSXV: LBL wb_incandescent

Details

Headquarters:

512 East Madison Avenue

Suite 101

Belgrade, MT 59714

United States

Phone: 406 570 2658

Fax: 480 739 2199